NHI Announces Public Offering Of Common Stock
National Health Investors (NYSE:NHI) has announced a public offering of 2,000,000 shares of its common stock. The offering includes a 30-day option for underwriters to purchase up to an additional 300,000 shares. NHI will enter into forward sale agreements with major financial institutions acting as forward purchasers. The company won't receive immediate proceeds from the sale but expects to settle the agreements within 12 months for cash. NHI plans to use the net proceeds for working capital, acquisitions, debt repayment, and mortgage investments. The offering is made under an effective shelf registration statement and will be conducted through a prospectus supplement and related documents available from the joint book-running managers: BofA Securities, J.P. Morgan, Wells Fargo Securities, and BMO Capital Markets.
National Health Investors (NYSE:NHI) ha annunciato un offerta pubblica di 2.000.000 azioni del proprio capitale sociale. L'offerta include un'opzione di 30 giorni per gli underwriter di acquistare fino a ulteriori 300.000 azioni. NHI stipulerà accordi di vendita anticipata con importanti istituzioni finanziarie che agiranno come acquirenti anticipati. L'azienda non riceverà proventi immediati dalla vendita, ma prevede di concludere gli accordi entro 12 mesi per contante. NHI prevede di utilizzare i proventi netti per capitale circolante, acquisizioni, rimborso di debiti e investimenti ipotecari. L'offerta è effettuata nell'ambito di un'efficace dichiarazione di registrazione a scaffale e sarà condotta tramite un supplemento di prospetto e documenti correlati disponibili dai manager di book-running: BofA Securities, J.P. Morgan, Wells Fargo Securities e BMO Capital Markets.
National Health Investors (NYSE:NHI) ha anunciado una oferta pública de 2.000.000 de acciones de su capital social. La oferta incluye una opción de 30 días para que los intermediarios compren hasta 300.000 acciones adicionales. NHI celebrará contratos de venta a futuro con importantes instituciones financieras que actuarán como compradores anticipados. La compañía no recibirá ingresos inmediatos de la venta, pero espera liquidar los acuerdos en un plazo de 12 meses por efectivo. NHI planea utilizar los ingresos netos para capital operativo, adquisiciones, pago de deudas e inversiones hipotecarias. La oferta se realiza bajo una declaración de registro en estante efectiva y se llevará a cabo a través de un suplemento de prospecto y documentos relacionados disponibles a través de los gerentes de libros conjuntos: BofA Securities, J.P. Morgan, Wells Fargo Securities y BMO Capital Markets.
National Health Investors (NYSE:NHI)는 2,000,000주의 보통주 공모를 발표했습니다. 이 공모는 언더라이터가 최대 추가 300,000주를 구매할 수 있는 30일 옵션을 포함합니다. NHI는 주요 금융 기관과 선매도 계약을 체결할 계획입니다. 회사는 판매로부터 즉각적인 수익을 얻지 않겠지만, 현금으로 12개월 이내에 계약을 정산할 것으로 예상하고 있습니다. NHI는 운전자본, 인수, 부채 상환 및 모기지 투자를 위해 순수익을 사용할 계획입니다. 이 공모는 유효한 선반 등록 성명서 하에 이루어지며, 공동 북런닝 관리자(BofA Securities, J.P. Morgan, Wells Fargo Securities 및 BMO Capital Markets)로부터 이용 가능한 잠정 보고서 및 관련 문서를 통해 진행됩니다.
National Health Investors (NYSE:NHI) a annoncé une offre publique de 2 000 000 d'actions de ses actions ordinaires. L'offre comprend une option de 30 jours pour les souscripteurs d'acheter jusqu'à 300 000 actions supplémentaires. NHI conclura des accords de vente à terme avec des institutions financières majeures agissant en tant qu'acheteurs à terme. L'entreprise ne recevra pas de produits immédiats de la vente, mais prévoit de régler les accords dans les 12 mois par des paiements en espèces. NHI prévoit d'utiliser les produits nets pour le fonds de roulement, des acquisitions, le remboursement de dettes et des investissements hypothécaires. L'offre est réalisée sous un état d'enregistrement d'étagère effectif et sera réalisée via un complément de prospectus et des documents connexes disponibles auprès des co-managers de book-running : BofA Securities, J.P. Morgan, Wells Fargo Securities et BMO Capital Markets.
National Health Investors (NYSE:NHI) hat ein Öffentliches Angebot von 2.000.000 Aktien ihrer Stammaktien angekündigt. Das Angebot beinhaltet eine 30-tägige Option für Underwriter, bis zu 300.000 zusätzliche Aktien zu erwerben. NHI wird Vorverkaufsvereinbarungen mit großen Finanzinstitutionen abschließen, die als Vorabkäufer fungieren. Das Unternehmen wird keine unmittelbaren Erlöse aus dem Verkauf erhalten, erwartet jedoch, die Vereinbarungen innerhalb von 12 Monaten in bar abzuwickeln. NHI plant, die Nettomittel für Betriebskapital, Akquisitionen, Schuldenrückzahlungen und Hypothekeninvestitionen zu verwenden. Das Angebot erfolgt im Rahmen einer gültigen Registierungsanmeldung und wird durch einen Prospektzusatz und verwandte Dokumente, die von den Joint Book-Running Managern, BofA Securities, J.P. Morgan, Wells Fargo Securities und BMO Capital Markets, erhältlich sind, durchgeführt.
- Potential to raise significant capital for strategic initiatives
- Flexibility in timing of share issuance through forward sale agreements
- Opportunity for expansion and acquisitions with new funds
- Ability to repay debt, potentially improving financial position
- Potential dilution of existing shareholders' ownership
- No immediate access to offering proceeds
- Possible downward pressure on stock price due to increased share supply
NHI's public offering of 2,000,000 shares of common stock, with an additional 300,000 shares option, is a significant capital-raising move. The use of forward sale agreements with major financial institutions is a strategic approach to optimize pricing and manage dilution. This structure allows NHI to lock in a price now while delaying the actual issuance of shares for up to 12 months, providing flexibility in timing the capital infusion. The intended use of proceeds for acquisitions, debt repayment and investments signals potential growth and balance sheet strengthening. However, investors should be aware of the potential dilution when the shares are eventually issued. The market's reaction will depend on how effectively NHI deploys this capital to generate returns above its cost of equity.
This offering by NHI, a healthcare REIT, reflects the company's strategy to capitalize on potential opportunities in the healthcare real estate sector. The timing suggests management sees favorable conditions for expansion or acquisitions. The flexibility to use proceeds for various purposes, including property acquisitions and debt repayment, indicates a balanced approach to growth and financial management. However, the success of this move hinges on NHI's ability to identify and execute value-accretive investments in the competitive healthcare real estate market. Investors should monitor the company's acquisition pipeline and cap rates on new investments to assess the potential return on this additional capital. The offering's impact on NHI's FFO per share and dividend coverage ratio will be important metrics to watch in the coming quarters.
NHI's stock offering comes at a time when the healthcare REIT sector is navigating challenges and opportunities posed by demographic trends and evolving healthcare delivery models. The company's decision to raise capital suggests confidence in its growth prospects, but also reflects the competitive pressure to scale up in the healthcare real estate market. The involvement of major financial institutions as underwriters lends credibility to the offering. However, the timing and pricing of the eventual share issuance will be critical, given the sensitivity of REITs to interest rate movements and sector-specific dynamics. Investors should consider this offering in the context of NHI's relative valuation to peers and its historical premium/discount to NAV. The market's reception of this offering could provide insights into investor sentiment towards the healthcare REIT sector as a whole.
MURFREESBORO, TN / ACCESSWIRE / August 14, 2024 / National Health Investors, Inc. (NYSE:NHI) (the "Company") announced today that it has commenced an underwritten public offering of 2,000,000 shares of its common stock, all of which will be offered on a forward basis through the forward purchasers (as defined below) or their respective affiliates in connection with the forward sale agreements described below. The underwriters of the offering also expect to be granted a 30-day option to purchase up to an additional 300,000 shares of the Company's common stock from the forward purchasers.
BofA Securities, J.P. Morgan, Wells Fargo Securities and BMO Capital Markets are acting as joint book-running managers for the offering and as representatives of the underwriters in the offering.
The Company expects to enter into separate forward sale agreements with each of BofA Securities, J.P. Morgan, Wells Fargo Securities and BMO Capital Markets (or their respective affiliates) (the "forward purchasers") with respect to the shares of common stock covered by the offering. In connection with the forward sale agreements, the forward purchasers or their respective affiliates are expected to borrow and sell to the underwriters all of the shares of common stock that will be delivered in the offering.
Subject to its right to elect cash or net share settlement under certain conditions, the Company intends to deliver, upon full physical settlement of the forward sale agreements on one or more dates specified by the Company occurring no later than approximately twelve months following the date of the prospectus supplement relating to the offering, an aggregate of 2,000,000 shares of common stock to the forward purchasers (or 2,300,000 shares of common stock if the underwriters exercise their option to purchase up to an additional 300,000 shares in full) in exchange for cash proceeds per share equal to the applicable forward sale price, which will initially be the public offering price less the underwriting discount and will be subject to certain adjustments as provided in the forward sale agreements.
The Company will not receive any proceeds from the sale of shares by the forward purchasers or their respective affiliates. The Company expects to use the net proceeds that it receives upon settlement of the forward sale agreements for working capital and for general corporate purposes, including, but not limited to, the funding of acquisitions of additional properties or businesses, the repayment of short-term and long-term debt and investments in mortgages.
The offering is being made pursuant to an effective shelf registration statement and will be made only by means of a preliminary prospectus supplement and a related prospectus relating to such offering and the accompanying base prospectus, a copy of which may be obtained from: BofA Securities, Inc., Attn: Prospectus Department, NCI-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, email dg.prospectus_requests@bofa.com; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at prospectus-eq_fi@jpmchase.com and postsalemanualrequests@broadridge.com; Wells Fargo Securities, LLC, 90 South 7th Street, 5th Floor, Minneapolis, MN 55402, at 800-645-3751 (option #5) or email a request to WFScustomerservice@wellsfargo.com; BMO Capital Markets Corp., Attn: Equity Syndicate Department, 151 W. 42nd Street, 32nd Floor, New York, NY 10036, email: bmoprospectus@bmo.com.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements including, without limitation, words such as "may", "will", "should", "believes", "anticipates", "expects", "intends", "estimates", "plans", "projects", "likely" and other similar expressions are forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Such risks and uncertainties include, among other things; the operating success of our tenants and borrowers for collection of our lease and interest income; the risk that our tenants and borrowers may become subject to bankruptcy or insolvency proceedings; risks related to the concentration of a significant percentage of our portfolio to a small number of tenants; risks associated with pandemics, epidemics or outbreaks, such as the COVID-19 pandemic, on our operators' business and results of operations; risks related to governmental regulations and payors, principally Medicare and Medicaid, and the effect that lower reimbursement rates would have on our tenants' and borrowers' business; the risk that the cash flows of our tenants and borrowers would be adversely affected by increased liability claims and liability insurance costs; the risk that we may not be fully indemnified by our lessees and borrowers against future litigation; the success of property development and construction activities, which may fail to achieve the operating results we expect; the risk that the illiquidity of real estate investments could impede our ability to respond to adverse changes in the performance of our properties; risks associated with our investments in unconsolidated entities, including our lack of sole decision-making authority and our reliance on the financial condition of other interests; inflation and increased interest rates; adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults, or non-performance by financial institutions; operational risks with respect to our senior housing operating portfolio structured communities; risks related to our ability to maintain the privacy and security of Company information; risks related to environmental laws and the costs associated with liabilities related to hazardous substances; the risk of damage from catastrophic weather and other natural or man-made disasters and the physical effects of climate change; the success of our future acquisitions and investments; our ability to reinvest cash in real estate investments in a timely manner and on acceptable terms; our ability to retain our management team and other personnel and attract suitable replacements should any such personnel leave; the risk that our assets may be subject to impairment charges; the potential need to incur more debt in the future, which may not be available on terms acceptable to us; our ability to meet covenants related to our indebtedness which impose certain operational limitations and a breach of those covenants could materially adversely affect our financial condition and results of operations; our dependence on revenues derived mainly from fixed rate investments in real estate assets, while a portion of our debt bears interest at variable rates; and our dependence on the ability to continue to qualify for taxation as a real estate investment trust and other risks which are described under the heading "Risk Factors" in Item 1A in our Form 10-K for the year ended December 31, 2023. Many of these factors are beyond the control of the Company and its management. The Company assumes no obligation to update any of the foregoing or any other forward looking statements, except as required by law, and these statements speak only as of the date on which they are made. Investors are urged to carefully review and consider the various disclosures made by NHI in its periodic reports filed with the Securities and Exchange Commission, including the risk factors and other information in the above referenced Form 10-K. Copies of each filing may be obtained from the Company or the SEC.
Contact: Dana Hambly, Vice President, Finance & Investor Relations
Phone: (615) 890-9100
SOURCE: National Health Investors
View the original press release on accesswire.com
FAQ
How many shares is NHI offering in its public offering?
What is the purpose of NHI's stock offering?
When will NHI receive the proceeds from the stock offering?
Who are the underwriters for NHI's stock offering?
